Free Trial

Sernova (TSE:SVA) Hits New 12-Month Low - Here's Why

Sernova logo with Medical background

Sernova Corp. (TSE:SVA - Get Free Report)'s stock price reached a new 52-week low on Friday . The company traded as low as C$0.21 and last traded at C$0.22, with a volume of 196750 shares traded. The stock had previously closed at C$0.22.

Wall Street Analyst Weigh In

SVA has been the subject of several recent analyst reports. Ventum Financial reduced their price objective on shares of Sernova from C$3.00 to C$2.50 and set a "buy" rating for the company in a research note on Friday, September 13th. Ventum Cap Mkts raised Sernova to a "strong-buy" rating in a research note on Thursday, September 12th. Finally, Leede Financial dropped their price objective on Sernova from C$3.00 to C$1.50 and set a "speculative buy" rating for the company in a research note on Friday, September 13th.

Check Out Our Latest Research Report on Sernova

Sernova Trading Up 2.3 %

The business's 50-day simple moving average is C$0.24 and its 200-day simple moving average is C$0.26. The company has a market cap of C$73.20 million, a price-to-earnings ratio of -1.73 and a beta of 1.35. The company has a debt-to-equity ratio of 16.55, a current ratio of 0.32 and a quick ratio of 18.11.

About Sernova

(Get Free Report)

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.

Read More

Should You Invest $1,000 in Sernova Right Now?

Before you consider Sernova, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sernova wasn't on the list.

While Sernova currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines